Join to View Full Profile
3400 Spruce StreetPhiladelphia, PA 19104
Dr. Soberman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2024 - 2027
University of Pennsylvania Health SystemResidency, Internal Medicine, 2021 - 2024
Donald and Barbara Zucker School of Medicine at Hofstra/NorthwellClass of 2021
University of PennsylvaniaMSE, Bioengineering, 2015 - 2016- The George Washington UniversityBS, Biomedical Engineering, summa cum laude, 2011 - 2015
Certifications & Licensure
PA State Medical License 2021 - 2025
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 1 citationsNanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis.Ivan S Alferiev, Kehan Zhang, Zoë Folchman-Wagner, Richard F Adamo, David T Guerrero
Pharmaceutics. 2024-01-29 - 3 citationsPoloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance.Ivan S Alferiev, David T Guerrero, Peng Guan, Ferro Nguyen, Venkatadri Kolla
FASEB Journal. 2022-03-01 - 3 citationsNanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models.Ivan S Alferiev, David T Guerrero, Danielle Soberman, Peng Guan, Ferro Nguyen
International Journal of Molecular Sciences. 2022-02-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
